Category:
Pandemic
Latest
Covid most transmissible 2 days before, 3 days after symptoms appear: Study
Half of hospitalised Covid patients have persisting symptoms after a year: Lancet study
“Our study is the largest to date to assess the health outcomes of hospitalised COVID-19 survivors after 12 months of becoming ill,” said Professor Bin Cao, from China-Japan Friendship Hospital.
“While most had made a good recovery, health problems persisted in some patients, especially those who had been critically ill during their hospital stay,” Cao said.
Vaccine airlift delivers shot in the arm for airlines
IATA, representing 290 airlines, warns that vaccine rollout could be “compromised” without an easing of the travel curbs and quarantines it has lobbied against.
“There are parts of the world that have no cargo operations once the passenger networks are grounded,” IATA head of cargo Glyn Hughes said.
India considering accelerated review of COVID-19 vaccine emergency use
“We are in the process of reviewing. It is an accelerated reviewing process, which is there for Serum too,” the government official said. “All applications are accelerated. It is the need of the hour.”
Country will not have to wait too long for COVID-19 Vaccine:PM Modi
“However, there should be no laxity from our side as far as prevention of the infection is concerned. Masks and a distance of two yards is very necessary,” Modi said.
Covid 19 Pandemic to hit life insurers’ investment income,ULIP and Pension and Annuity business:LIC Chief
TR Alamelu, member, IRDAI explained that that the solution to the issue of under-insurance in the country does not lie in mandating insurance because a stage has been reached where insurance should be a product on “demand” and It cannot be forced upon consumers by the industry or other stakeholders.
Tokyo Olympics delay costs near $2.8 billion
About two-thirds of the added costs are being picked up by the two government entities, with the other one-third going to the privately funded organizing committee.
Serum likely to supply COVID-19 vaccine at over $3 a dose to Indian government
The government is pinning its hopes for mass supply on Serum Institute, which lodged the first formal application for emergency-use approval of AstraZeneca’s shot on Monday.
Chief Executive Officer Adar Poonawalla had earlier said the vaccine would be priced at 1,000 rupees ($13.55) per dose in India’s private market, but governments signing large supply deals would likely buy it at lower prices.
A year into COVID-19, U.N. declares a day of ‘epidemic preparednes
The COVID-19 virus emerged in the Chinese city of Wuhan late last year and spread globally, so far infecting more than 66 million people and killing some 1.5 million. The World Health Organization (WHO) called it a pandemic in March, a declaration that the United States and others said came too late.
“Given that the General Assembly has previously declared international days devoted to chess, yoga and toilets it only seems fair that epidemics should have their day too,” said International Crisis Group U.N. director Richard Gowan.
Personal accident and health insurance in Asia-Pacific to reach $240.1bn in 2023:GlobalData
Varma concludes: “Personal accident and health insurance insurance is expected to see major developments as short-term accident covers, critical illness, disease-specific products become more mainstream. Furthermore, technology savvy middle class emerging markets and aging population in mature markets will support the business growth over the next few years.”
AstraZeneca and Oxford’s stories clash on COVID-19 vaccine
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data
India should begin scaling up syringe stocks for Covid vaccination: Experts
According to Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd, the estimated demand in India would be around 900 million pieces of different kinds of syringes for just one shot of the vaccine, considering 60-70 per cent of the country gets vaccinated.
“The number would amplify to 1.8 billion if the vaccine India chooses needs two shots,” Nath told IANS.